Ikarian Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Buy |
+21,516
| New | +$2.7M | 0.52% | 33 |
|
|
2023
Q2 | – | Sell |
-962
| Closed | -$267K | – | 93 |
|
|
2023
Q1 | $267K | Hold |
962
| – | – | 0.06% | 76 |
|
|
2022
Q4 | $266K | Sell |
962
-10,000
| -91% | -$2.77M | 0.06% | 53 |
|
|
2022
Q3 | $2.93M | Buy |
10,962
+9,840
| +877% | +$2.63M | 0.58% | 27 |
|
|
2022
Q2 | $228K | Hold |
1,122
| – | – | 0.04% | 76 |
|
|
2022
Q1 | $237K | Sell |
1,122
-28,411
| -96% | -$6M | 0.03% | 121 |
|
|
2021
Q4 | $7.09M | Sell |
29,533
-2,710
| -8% | -$650K | 1.06% | 12 |
|
|
2021
Q3 | $9.12M | Sell |
32,243
-93,719
| -74% | -$26.5M | 0.64% | 12 |
|
|
2021
Q2 | $43.6M | Buy |
125,962
+120,262
| +2,110% | +$41.6M | 3.53% | 1 |
|
|
2021
Q1 | $1.59M | Hold |
5,700
| – | – | 0.05% | 114 |
|
|
2020
Q4 | $1.4M | Buy |
5,700
+2,700
| +90% | +$661K | 0.06% | 83 |
|
|
2020
Q3 | $852K | Buy |
3,000
+2,205
| +277% | +$626K | 0.06% | 71 |
|
|
2020
Q2 | $213K | Hold |
795
| – | – | 0.02% | 70 |
|
|
2020
Q1 | $252K | Buy |
+795
| New | +$252K | 0.02% | 69 |
|